Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice
- 1 February 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (3) , 406-411
- https://doi.org/10.1016/s0959-8049(97)10034-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanomaCancer, 1994
- Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycleInternational Journal of Cancer, 1994
- Inhibitors of ras farnesyltransferasesTrends in Biochemical Sciences, 1993
- A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanomaCancer, 1993
- Protein Prenylation: a Mediator of Protein-Protein InteractionsScience, 1993
- Inhibition of pancreatic adenocarcinoma cell growth by lovastatinGastroenterology, 1992
- Cell cycle-specific effects of lovastatin.Proceedings of the National Academy of Sciences, 1991
- Lovastatin, a Cholesterol Biosynthesis Inhibitor, Inhibits the Growth of Human H-ras Oncogene Transformed Cells in Nude MiceCancer Communications, 1991
- Discovery, biochemistry and biology of lovastatinThe American Journal of Cardiology, 1988
- Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.Journal of Clinical Investigation, 1985